Literature DB >> 9974426

Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia.

S Bertolini1, S Cassanelli, R Garuti, M Ghisellini, M L Simone, M Rolleri, P Masturzo, S Calandra.   

Abstract

The aim of this study was the characterization of mutations of the LDL receptor gene in 39 Italian patients with homozygous familial hypercholesterolemia, who were examined during the period 1994 to 1996. The age of the patients ranged from 1 to 64 years; one third of them were older than 30. Plasma LDL cholesterol level ranged from 10.8 to 25.1 mmol/L. The residual LDL receptor activity, measured in cultured fibroblasts of 32 patients, varied from <2% to 30% of normal and was inversely correlated with the plasma LDL cholesterol level (r=-0.665; P<0.003). The most severe coronary atherosclerosis was observed in those patients with the lowest residual LDL receptor activity (</=5% of normal) and the highest plasma LDL cholesterol levels. Twenty-nine patients (23 of whom were unrelated) were found to be homozygotes at the LDL receptor locus. In this group we discovered 2 major rearrangements and 12 different point mutations (9 in the coding region and 3 in splice sites). Some mutations (D200G, C358R, V502M, G528D, and P664L) were found in 3 or more unrelated patients. Patients with the same mutation shared the same haplotype at the LDL receptor gene locus and came from the same geographic area. Ten patients (9 of whom were unrelated) were found to be compound heterozygotes. The mutations found in this group consisted of one large deletion and 12 point mutations (11 in the coding sequence and one in a splice site). In 3 compound heterozygotes we failed to identify the second mutant allele at the LDL receptor locus. These observations confirm the allelic heterogeneity underlying familial hypercholesterolemia in the Italian population and indicate that the variability of phenotypic expression of homozygous familial hypercholesterolemia is, to a large extent, related to the type of mutation of the LDL receptor gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9974426     DOI: 10.1161/01.atv.19.2.408

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  15 in total

1.  An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations.

Authors:  Maria Romano; Maria Donata Di Taranto; Peppino Mirabelli; Maria Nicoletta D'Agostino; Arcangelo Iannuzzi; Gennaro Marotta; Marco Gentile; Maddalena Raia; Rosa Di Noto; Luigi Del Vecchio; Paolo Rubba; Giuliana Fortunato
Journal:  J Lipid Res       Date:  2011-08-24       Impact factor: 5.922

2.  Structure-Function Relationships of LDL Receptor Missense Mutations Using Homology Modeling.

Authors:  Sureerut Porntadavity; Nutjaree Jeenduang
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

Review 3.  The panorama of familial hypercholesterolemia in Latin America: a systematic review.

Authors:  Roopa Mehta; Rafael Zubirán; Alexandro J Martagón; Alejandra Vazquez-Cárdenas; Yayoi Segura-Kato; María Teresa Tusié-Luna; Carlos A Aguilar-Salinas
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

4.  Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma.

Authors:  Leilei Zhang; Renbing Jia; Junyang Zhao; Jiayan Fan; YiXiong Zhou; Bing Han; Xin Song; Li Wu; He Zhang; Huaidong Song; Shengfang Ge; Xianqun Fan
Journal:  Tumour Biol       Date:  2014-11-27

Review 5.  Optimal management of familial hypercholesterolemia: treatment and management strategies.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh
Journal:  Vasc Health Risk Manag       Date:  2010-12-03

Review 6.  Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review.

Authors:  L Iughetti; B Predieri; F Balli; S Calandra
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

Review 7.  Dominant versus recessive: molecular mechanisms in metabolic disease.

Authors:  Johannes Zschocke
Journal:  J Inherit Metab Dis       Date:  2008-10-21       Impact factor: 4.982

8.  Clinical course of homozygous familial hypercholesterolemia during childhood: report on 4 unrelated patients with homozygous or compound heterozygous mutations in the LDLR gene.

Authors:  Jolanta Kubalska; Magdalena Chmara; Janusz Limon; Aldona Wierzbicka; Sylwester Prokurat; Janina Szaplyko; Agnieszka Kowalik; Hanna Mierzewska; Joep C Defesche; Ewa Pronicka
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

9.  Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction.

Authors:  Aenne S Thormaehlen; Christian Schuberth; Hong-Hee Won; Peter Blattmann; Brigitte Joggerst-Thomalla; Susanne Theiss; Rosanna Asselta; Stefano Duga; Pier Angelica Merlini; Diego Ardissino; Eric S Lander; Stacey Gabriel; Daniel J Rader; Gina M Peloso; Rainer Pepperkok; Sekar Kathiresan; Heiko Runz
Journal:  PLoS Genet       Date:  2015-02-03       Impact factor: 5.917

10.  Use of targeted exome sequencing in genetic diagnosis of Chinese familial hypercholesterolemia.

Authors:  Wen-Feng Wu; Li-Yuan Sun; Xiao-Dong Pan; Shi-Wei Yang; Lv-Ya Wang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.